General Information of Drug (ID: DMTA5OE)

Drug Name
Azacitidine Drug Info
Synonyms
Azacitidina; Azacitidinum; Azacytidine; Ladakamycin; Mylosar; Vidaza; Mylo sar; Pharmion Brand of Azacitidine;A 2385; Antibiotic U 18496; U 18496; Wr 183027; Azacitidina [INN-Spanish]; Azacitidine [USAN:INN]; Azacitidinum [INN-Latin]; NS-17; Pyrimidine antimetabolite: inhibits nucleic acid replication; U-18496; Vidaz (TN); Vidaza (TN); WR-183027; Azacitidine (JAN/USAN/INN); S-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-(8CI); 2-(beta-D-Ribofuranosyl)-4-amino-1,3,5-triazin-2-one; 4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one; 4-Amino-1-beta-D-ribofuranosyl-1,3,5-traizin-2(1H)-one; 4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one; 4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one; 4-Amino-1-beta-d-ribofuranosyl-1,3,5-triazin-2(1H)-one; 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triaz; 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one; 4-amino-1-beta-L-ribofuranosyl-1,3,5-triazin-2(1H)-one; 5 AZC; 5 Azacytidine; 5-AC; 5-AZAC; 5-AZCR; 5-aza-CR; 5-azacitidine; 5-azacytidine; 5-azacytidine, Mylosar, Ladakamycin, Vidaza, Azacitidine; 5AzaC
Indication
Disease Entry ICD 11 Status REF
Acute myelogenous leukaemia 2A41 Approved [1]
Chronic myelomonocytic leukemia Approved [1]
Leukemia Approved [1]
Myelodysplastic syndrome 2A37 Approved [2]
Myeloproliferative neoplasm 2A20 Approved [1]
Plasma cell myeloma 2A83.1 Approved [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
9444
ChEBI ID
CHEMBL1489
CAS Number
CAS 320-67-2
TTD Drug ID
DMTA5OE
VARIDT Drug ID
DR00983
INTEDE Drug ID
DR0163

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DME
DOT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Investigative Drug(s)
Approved Drug(s)
Preclinical Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [11]
S-110 DMXY34J Acute myeloid leukaemia 2A60 Phase 3 [12]
ASTX727 DM4HK8Z Chronic myelogenous leukaemia 2A20.0 Phase 3 [13]
PMID27376512-Compound-PG-11047 DM5K4YF N. A. N. A. Patented [14]
PMID27376512-Compound-PG-11048 DM3U7RN N. A. N. A. Patented [14]
PMID27376512-Compound-MTC-434 DM70CTE N. A. N. A. Patented [14]
PMID27376512-Compound-CROs DMBFUTL N. A. N. A. Patented [14]
(L-)-S-adenosyl-L-homocysteine DMDUN83 Discovery agent N.A. Investigative [15]
NSC-622445 DME35CB Discovery agent N.A. Investigative [11]
NSC-622444 DMM5UT9 Discovery agent N.A. Investigative [11]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytidine aminohydrolase (CDA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [16]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [17]
Capecitabine DMTS85L Adenocarcinoma 2D40 Approved [18]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [19]
Drug(s) Metabolized By Cytidine deaminase (cdd)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [5]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [5]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [5]
Drug(s) Affected By Bcl-2-like protein 1 (BCL2L1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [20]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [21]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [22]
Selenium DM25CGV N. A. N. A. Approved [23]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [24]
Methotrexate DM2TEOL Anterior urethra cancer Approved [25]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [26]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [27]
Quercetin DM3NC4M Obesity 5B81 Approved [28]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [29]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [33]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [35]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [36]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [41]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [44]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [45]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [46]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [48]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [49]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [51]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-A9 (S100A9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [52]
Methotrexate DM2TEOL Anterior urethra cancer Approved [53]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [54]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [55]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [55]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [56]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [57]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [58]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [59]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [53]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [61]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [62]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [63]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [64]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [65]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [66]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [67]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [69]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [70]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [71]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [72]
Quercetin DM3NC4M Obesity 5B81 Approved [73]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [74]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [75]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [76]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [77]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [80]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Folic Acid DMEMBJC Colorectal carcinoma Approved [81]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [82]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [83]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [46]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Transcription factor E3 (TFE3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [86]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [87]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [87]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [87]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [88]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-P (S100P)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [89]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [90]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [72]
Quercetin DM3NC4M Obesity 5B81 Approved [91]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [92]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [93]
Estrone DM5T6US Acne vulgaris ED80 Approved [94]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [96]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein PML (PML)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [97]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [98]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [92]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Menthol DMG2KW7 Back pain ME84.Z Approved [100]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [101]
Epirubicin DMPDW6T Solid tumour/cancer 2A00-2F9Z Approved [101]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [102]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [103]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [104]
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [105]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [106]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [108]
Gefitinib DM15F0X Colon adenocarcinoma Approved [109]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [104]
Prednisone DM2HG4X Acute asthma CA23 Approved [110]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [112]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [49]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [47]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [49]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Testosterone enanthate DMB6871 N. A. N. A. Approved [113]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Bortezomib DMNO38U Leukemia Approved [114]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Testosterone enanthate DMB6871 N. A. N. A. Approved [113]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
Arsenic DMTL2Y1 N. A. N. A. Approved [117]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Selenium DM25CGV N. A. N. A. Approved [23]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [54]
Quercetin DM3NC4M Obesity 5B81 Approved [118]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [55]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [55]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [114]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [10]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [120]
Topotecan DMP6G8T Central nervous system neoplasm Approved [45]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
SB-431542 DM0YOXQ Pulmonary fibrosis CB03.4 Preclinical [121]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [122]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [123]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Claudin-10 (CLDN10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [124]
Quercetin DM3NC4M Obesity 5B81 Approved [91]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Folic Acid DMEMBJC Colorectal carcinoma Approved [126]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [127]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [127]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
Tetracycline DMZA017 Acne vulgaris ED80 Approved [128]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [129]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [130]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [131]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Testosterone enanthate DMB6871 N. A. N. A. Approved [113]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [132]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [103]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [133]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [134]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [135]
Methotrexate DM2TEOL Anterior urethra cancer Approved [53]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [74]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [136]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [137]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [98]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [62]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Testosterone enanthate DMB6871 N. A. N. A. Approved [113]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ethanol DMDRQZU Chronic pain MG30 Approved [140]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [10]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [67]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
Adenosine DMM2NSK Paroxysmal supraventricular tachycardia BC81.Z Approved [144]
Uridine DMQTREB Depression 6A70-6A7Z Approved [145]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytohesin-1 (CYTH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [146]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [147]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [67]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [148]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [149]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [10]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [150]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Testosterone enanthate DMB6871 N. A. N. A. Approved [113]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [152]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [152]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [10]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [67]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [23]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tetraspanin-32 (TSPAN32)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [153]
Mivebresib DMCPF90 Acute myeloid leukaemia 2A60 Phase 1 [154]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Tribbles homolog 1 (TRIB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [89]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Menthol DMG2KW7 Back pain ME84.Z Approved [100]
Mecamylamine DMGQFYB Essential hypertension BA00 Approved [157]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [158]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [159]
Bortezomib DMNO38U Leukemia Approved [114]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [160]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [161]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Centromere protein O (CENPO)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [49]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [82]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [162]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
GSK2110183 DMZHB37 leukaemia 2A60-2B33 Phase 2 [163]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [164]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Folic Acid DMEMBJC Colorectal carcinoma Approved [126]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [129]
Bortezomib DMNO38U Leukemia Approved [114]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Arsenic DMTL2Y1 N. A. N. A. Approved [165]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [23]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Panobinostat DM58WKG Chronic graft versus host disease Approved [166]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [10]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [168]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Bortezomib DMNO38U Leukemia Approved [114]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [169]
Arsenic DMTL2Y1 N. A. N. A. Approved [165]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [162]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [170]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [159]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [171]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [41]
Bortezomib DMNO38U Leukemia Approved [114]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [150]
Isoflavone DM7U58J N. A. N. A. Phase 4 [172]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [153]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [173]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [114]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [10]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [174]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [123]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [175]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [10]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [176]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [161]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [177]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [178]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Protein FAM8A1 (FAM8A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [10]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [35]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [161]
Milchsaure DM462BT Pruritus EC90 Investigative [179]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [46]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Testosterone enanthate DMB6871 N. A. N. A. Approved [113]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [33]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [180]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [181]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [170]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [158]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [33]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [182]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [183]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [185]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [41]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Syntenin-1 (SDCBP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [186]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [186]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [187]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [41]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Benzatropine DMF7EXL Parkinsonian disorder Approved [188]
Clozapine DMFC71L Schizophrenia 6A20 Approved [188]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Complexin-1 (CPLX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [148]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [189]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [46]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Nephrocystin-1 (NPHP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [178]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [44]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [31]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [190]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Menthol DMG2KW7 Back pain ME84.Z Approved [100]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [192]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Hydroxychloroquine DMSIVND Chronic renal failure GB61.Z Approved [193]
Arsenic DMTL2Y1 N. A. N. A. Approved [194]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Diphenylpyraline DMW4X37 Allergic rhinitis CA08.0 Approved [195]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pentoxifylline DMU3DNC Alcoholic hepatitis DB94.1 Approved [196]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [197]
Verapamil DMA7PEW Angina pectoris BA40 Approved [198]
Selenium DM25CGV N. A. N. A. Approved [199]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [198]
Quercetin DM3NC4M Obesity 5B81 Approved [200]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [201]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [203]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [204]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cystatin-C (CST3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [62]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [181]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [205]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [206]
Gentamicin DMKINJO Bacteremia 1A73 Approved [207]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cystatin-S (CST4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [41]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [108]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [209]
Etretinate DM2CZFA Keratosis ED56 Approved [210]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [211]
Methotrexate DM2TEOL Anterior urethra cancer Approved [25]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [212]
Quercetin DM3NC4M Obesity 5B81 Approved [213]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [214]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [215]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [56]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [124]
Selenium DM25CGV N. A. N. A. Approved [23]
Methotrexate DM2TEOL Anterior urethra cancer Approved [216]
Quercetin DM3NC4M Obesity 5B81 Approved [217]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [74]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [218]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [219]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [55]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [55]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [220]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [55]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [221]
Etretinate DM2CZFA Keratosis ED56 Approved [222]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [221]
Quercetin DM3NC4M Obesity 5B81 Approved [223]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [201]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [221]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [224]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [221]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Profilin-1 (PFN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [225]
Selenium DM25CGV N. A. N. A. Approved [23]
Etretinate DM2CZFA Keratosis ED56 Approved [222]
Quercetin DM3NC4M Obesity 5B81 Approved [226]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [227]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [86]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [228]
Haloperidol DM96SE0 Delirium Approved [188]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [229]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tropomyosin beta chain (TPM2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Benzatropine DMF7EXL Parkinsonian disorder Approved [188]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [206]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [158]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [225]
Quercetin DM3NC4M Obesity 5B81 Approved [223]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [230]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [231]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [232]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [233]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [234]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [67]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Glycodelin (PAEP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [49]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [47]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [205]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [88]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [235]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [149]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [236]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [41]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [114]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [237]
PEITC DMOMN31 Prostate cancer 2C82.0 Phase 2 [238]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [62]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [239]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [147]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [51]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [240]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Ceruletide DM2WE5K Caerulein stimulated gastric and pancreatic secretion 5A4Y Approved [241]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [242]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Testosterone DM7HUNW Hot flushes GA30 Approved [243]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [123]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Plastin-3 (PLS3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Haloperidol DM96SE0 Delirium Approved [188]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Clozapine DMFC71L Schizophrenia 6A20 Approved [188]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [244]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [31]
Arsenic DMTL2Y1 N. A. N. A. Approved [117]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [245]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [246]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [246]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [246]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [187]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Desmin (DES)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [173]
Selenium DM25CGV N. A. N. A. Approved [23]
Methotrexate DM2TEOL Anterior urethra cancer Approved [247]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [248]
Artesunate DMR27C8 Infection of P. falciparum 1F40 Approved [249]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [250]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [251]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [196]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By 5'-nucleotidase (NT5E)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [252]
Quercetin DM3NC4M Obesity 5B81 Approved [253]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [146]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [130]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [47]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [41]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [129]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Methotrexate DM2TEOL Anterior urethra cancer Approved [137]
Quercetin DM3NC4M Obesity 5B81 Approved [91]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [239]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [255]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [137]
Nifedipine DMSVOZT Angina pectoris BA40 Approved [256]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [257]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [258]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [259]
Selenium DM25CGV N. A. N. A. Approved [23]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [260]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [62]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [261]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [262]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [46]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [104]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [120]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [263]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [161]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [264]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [149]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [265]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [266]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein ITPRID2 (ITPRID2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [33]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [267]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [268]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [269]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [270]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [271]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [272]
Capsaicin DMGMF6V Back pain ME84.Z Approved [273]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [274]
Bryostatin-1 DM1JOXY Alzheimer disease 8A20 Phase 2 [275]
RGI-2001 DM4AC2F Graft-versus-host disease 4B24 Phase 2 [276]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neurotensin/neuromedin N (NTS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [277]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [48]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [278]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [187]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [237]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [45]
Bicalutamide DMZMSPF Prostate cancer 2C82.0 Approved [279]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [278]
phorbol 12-myristate 13-acetate DMJWD62 Acute myeloid leukaemia 2A60 Phase 2 [277]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [92]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [49]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Testosterone enanthate DMB6871 N. A. N. A. Approved [113]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [41]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [280]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [69]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [281]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [69]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [282]
Arsenic DMTL2Y1 N. A. N. A. Approved [283]
Ritonavir DMU764S Human immunodeficiency virus infection 1C62 Approved [281]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [284]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [285]
Gefitinib DM15F0X Colon adenocarcinoma Approved [286]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [287]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [72]
Etretinate DM2CZFA Keratosis ED56 Approved [288]
Prednisone DM2HG4X Acute asthma CA23 Approved [110]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [289]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [135]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [290]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [265]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [291]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [41]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [178]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Alpha-S1-casein (CSN1S1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [292]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [92]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [293]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [185]
Teniposide DMLW57T Acute lymphoblastic leukaemia 2A85 Approved [294]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [295]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [41]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [296]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [31]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [45]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [297]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ephrin-A3 (EFNA3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [82]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [178]
KOJIC ACID DMP84CS Discovery agent N.A. Investigative [298]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Uracil mustard DMHL7OB Acute myeloid leukaemia 2A60 Approved [196]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [46]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [225]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [87]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [87]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [41]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [87]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [55]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [55]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [65]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [55]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [51]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [299]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Laminin subunit beta-2 (LAMB2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Quercetin DM3NC4M Obesity 5B81 Approved [300]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [301]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [51]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [33]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By NHP2-like protein 1 (SNU13)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [218]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [165]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [23]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [302]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PP-242 DM2348V Discovery agent N.A. Investigative [303]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [177]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein DLX-6 (DLX6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [205]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [31]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [138]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Etretinate DM2CZFA Keratosis ED56 Approved [222]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [260]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [304]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [186]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [219]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [229]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Menthol DMG2KW7 Back pain ME84.Z Approved [100]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [129]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [248]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [251]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [149]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [60]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [158]
Bortezomib DMNO38U Leukemia Approved [114]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [305]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caldesmon (CALD1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [306]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [62]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [41]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Benzatropine DMF7EXL Parkinsonian disorder Approved [188]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [308]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [309]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [158]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [310]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [33]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [174]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [173]
Quercetin DM3NC4M Obesity 5B81 Approved [311]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [67]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [312]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [104]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [86]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Hesperidin DMI5DW1 Vascular purpura 3B60 Approved [313]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [152]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [148]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [314]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [152]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Chitotriosidase-1 (CHIT1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [236]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [315]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [161]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [316]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [82]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [127]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [67]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [314]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [146]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [173]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [317]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [305]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [176]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [305]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [161]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [74]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [49]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Bortezomib DMNO38U Leukemia Approved [114]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [318]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [83]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [319]
COUMESTROL DM40TBU Discovery agent N.A. Investigative [320]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [321]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [87]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [47]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [87]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [41]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [248]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [322]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [46]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Testosterone enanthate DMB6871 N. A. N. A. Approved [113]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [323]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Quercetin DM3NC4M Obesity 5B81 Approved [91]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [23]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [153]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [324]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Reticulocalbin-1 (RCN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Haloperidol DM96SE0 Delirium Approved [188]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [206]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [67]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [33]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Olfactory receptor 8B8 (OR8B8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Folic Acid DMEMBJC Colorectal carcinoma Approved [126]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [225]
Selenium DM25CGV N. A. N. A. Approved [23]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [218]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [325]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Clozapine DMFC71L Schizophrenia 6A20 Approved [188]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [158]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Guanylate kinase (GUK1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aspirin DM672AH Acute coronary syndrome BA41 Approved [86]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [67]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [153]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [46]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [326]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [327]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [65]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ampicillin DMHWE7P Acute epiglottitis Approved [47]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [148]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [328]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [305]
Sodium phenylbutyrate DMXLBCQ Spinal muscular atrophy 8B61 Approved [329]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [161]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [46]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [51]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [330]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [56]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [158]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [171]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [181]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [162]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [51]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [314]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Bortezomib DMNO38U Leukemia Approved [114]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [44]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [148]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [251]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [331]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [161]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Panobinostat DM58WKG Chronic graft versus host disease Approved [166]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [332]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [138]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [166]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [46]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [89]
Quercetin DM3NC4M Obesity 5B81 Approved [333]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [334]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [335]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [137]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [132]
Ergocalciferol DMHO0AR Hypoparathyroidism 5A50 Approved [336]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Selenium DM25CGV N. A. N. A. Approved [23]
Quercetin DM3NC4M Obesity 5B81 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [23]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [306]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [74]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [105]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Mebendazole DMO14SG Ascariasis 1F62 Approved [337]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [152]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [127]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [338]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [176]
PDX-101 DM6OC53 Plasma cell myeloma 2A83.1 Phase 2 [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [46]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [161]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [138]
Folic Acid DMEMBJC Colorectal carcinoma Approved [126]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [170]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [339]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [314]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [67]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [340]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Eyes absent homolog 1 (EYA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [46]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [341]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [341]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [341]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [341]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [341]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [341]
Dabigatran DMDI6R4 Stroke 8B20 Approved [341]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [341]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [252]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [147]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [342]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
Duvelisib DM7USVA Follicular lymphoma 2A80 Phase 2 Trial [343]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [161]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [122]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By RNA helicase Mov10l1 (MOV10L1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [46]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [308]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [54]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [344]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [49]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [345]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Folic Acid DMEMBJC Colorectal carcinoma Approved [126]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [346]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [60]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Semaphorin-6C (SEMA6C)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [314]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [35]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [161]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [187]
Bortezomib DMNO38U Leukemia Approved [114]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [347]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [161]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [319]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [348]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Protocadherin-18 (PCDH18)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [349]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [83]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [350]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [46]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [123]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Protein S100-A14 (S100A14)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [146]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [351]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [120]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [352]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tryptase gamma (TPSG1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [148]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Folic Acid DMEMBJC Colorectal carcinoma Approved [353]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [159]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [161]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [161]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [354]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neuroligin-3 (NLGN3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [355]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Folic Acid DMEMBJC Colorectal carcinoma Approved [126]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
PDX-101 DM6OC53 Plasma cell myeloma 2A83.1 Phase 2 [138]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [37]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [46]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [356]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [236]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [74]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [357]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [130]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [131]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [175]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [51]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [48]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [148]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [129]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [114]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [31]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [114]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [174]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [244]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [127]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [127]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [153]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Protocadherin beta-4 (PCDHB4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [83]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [325]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [138]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [314]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [83]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [138]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [65]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [162]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Methamphetamine DMPM4SK Anxiety Approved [358]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [359]
Afimoxifene DMFORDT Breast cancer 2C60-2C65 Phase 2 [332]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Albumin (ALB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [196]
Tolbutamide DM02AWV Advanced cancer 2A00-2F9Z Approved [360]
Diazepam DM08E9O Alcohol withdrawal Approved [361]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [362]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [363]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [364]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [365]
Methotrexate DM2TEOL Anterior urethra cancer Approved [366]
Quercetin DM3NC4M Obesity 5B81 Approved [367]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Colchicine DM2POTE Acute gout flare FA25.0 Approved [368]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [369]
Bosentan DMIOGBU Pulmonary arterial hypertension BB01.0 Approved [370]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [371]
Miconazole DMPMYE8 Cutaneous candidiasis 1F23.14 Approved [372]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [342]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [60]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [169]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [373]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [374]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [375]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [376]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Efavirenz DMC0GSJ Human immunodeficiency virus infection 1C62 Approved [376]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [377]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [260]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [58]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [88]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Chenodiol DMQ8JIK Cholelithiasis DC11 Approved [378]
Mitomycin DMH0ZJE Breast cancer 2C60-2C65 Approved [45]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [205]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [82]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [127]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [127]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [83]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [379]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Claudin-7 (CLDN7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [380]
Methotrexate DM2TEOL Anterior urethra cancer Approved [25]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [65]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Folic Acid DMEMBJC Colorectal carcinoma Approved [126]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [170]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Claudin-9 (CLDN9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [380]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [148]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [305]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [381]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [71]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [258]
Gefitinib DM15F0X Colon adenocarcinoma Approved [109]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [56]
Selenium DM25CGV N. A. N. A. Approved [382]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [383]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [384]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [385]
Methotrexate DM2TEOL Anterior urethra cancer Approved [53]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Calcitonin (CALCA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ranitidine DM0GUSX Gastric ulcer DA60 Approved [386]
Fructose DM43AN2 Vomiting MD90 Approved [387]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [187]
Folic Acid DMEMBJC Colorectal carcinoma Approved [126]
Nizatidine DMGFV3Z Acid-reflux disorder DA22 Approved [386]
Capsaicin DMGMF6V Back pain ME84.Z Approved [388]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [389]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [93]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ethanol DMDRQZU Chronic pain MG30 Approved [390]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [129]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [391]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [317]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [129]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [392]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [393]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [229]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [129]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Histone H1.0 (H1-0)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [130]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ethanol DMDRQZU Chronic pain MG30 Approved [394]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [31]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [395]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [201]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [396]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Testosterone enanthate DMB6871 N. A. N. A. Approved [113]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [123]
Emetine DMCT2YF Hepatitis virus infection 1E50-1E51 Approved [397]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [398]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [88]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Gamma-enolase (ENO2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [399]
Estrone DM5T6US Acne vulgaris ED80 Approved [94]
Aluminium DM6ECN9 Hyperhidrosis EE00 Approved [400]
LY2835219 DM93VBZ Breast cancer 2C60-2C65 Approved [401]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [87]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [87]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Chromogranin-A (CHGA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [402]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [159]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [403]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [404]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [405]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [138]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cadherin-1 (CDH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [124]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [406]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [407]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [408]
Liraglutide DM3FXPS Non-insulin dependent diabetes 5A11 Approved [409]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [410]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [411]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [53]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [98]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [236]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [412]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [49]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Flurbiprofen DMGN4BY Osteoarthritis FA00-FA05 Approved [412]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Histone H2AX (H2AX)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [413]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [414]
Selenium DM25CGV N. A. N. A. Approved [23]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [415]
Etretinate DM2CZFA Keratosis ED56 Approved [416]
Methotrexate DM2TEOL Anterior urethra cancer Approved [417]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [418]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [419]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [420]
Quercetin DM3NC4M Obesity 5B81 Approved [421]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [422]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [93]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [423]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [424]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [425]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [426]
Dacarbazine DMNPZL4 Adenocarcinoma 2D40 Approved [427]
Topotecan DMP6G8T Central nervous system neoplasm Approved [428]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fibulin-1 (FBLN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [46]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Selenium DM25CGV N. A. N. A. Approved [23]
Methotrexate DM2TEOL Anterior urethra cancer Approved [137]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [137]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [62]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [429]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [65]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [70]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [71]
Gefitinib DM15F0X Colon adenocarcinoma Approved [430]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [431]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [245]
Methotrexate DM2TEOL Anterior urethra cancer Approved [432]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [433]
Quercetin DM3NC4M Obesity 5B81 Approved [434]
Furazolidone DM3P6V7 Diarrhea ME05.1 Approved [435]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [436]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [173]
Selenium DM25CGV N. A. N. A. Approved [382]
Methotrexate DM2TEOL Anterior urethra cancer Approved [25]
Quercetin DM3NC4M Obesity 5B81 Approved [118]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [437]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [438]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [284]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [439]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [108]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [173]
Prednisone DM2HG4X Acute asthma CA23 Approved [110]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [440]
Quercetin DM3NC4M Obesity 5B81 Approved [28]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [136]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [441]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [442]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [443]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [444]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [114]
Arsenic DMTL2Y1 N. A. N. A. Approved [165]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [165]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Arsenic DMTL2Y1 N. A. N. A. Approved [165]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [47]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
PMID28870136-Compound-48 DMPIM9L N. A. N. A. Patented [168]
QUERCITRIN DM1DH96 Discovery agent N.A. Investigative [445]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Arsenic DMTL2Y1 N. A. N. A. Approved [165]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [446]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Bortezomib DMNO38U Leukemia Approved [114]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [447]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [46]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [46]
Gefitinib DM15F0X Colon adenocarcinoma Approved [448]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [449]
Epinephrine DM3KJBC Acute asthma CA23 Approved [450]
Quercetin DM3NC4M Obesity 5B81 Approved [451]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [29]
Fructose DM43AN2 Vomiting MD90 Approved [387]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [452]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [453]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [454]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tuberin (TSC2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [104]
Selenium DM25CGV N. A. N. A. Approved [23]
Methotrexate DM2TEOL Anterior urethra cancer Approved [53]
Quercetin DM3NC4M Obesity 5B81 Approved [118]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [455]
Methamphetamine DMPM4SK Anxiety Approved [456]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [457]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [458]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [124]
Selenium DM25CGV N. A. N. A. Approved [23]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [459]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [460]
Methotrexate DM2TEOL Anterior urethra cancer Approved [461]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [29]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [182]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [462]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [317]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [35]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
AHPN DM8G6O4 Discovery agent N.A. Investigative [463]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [104]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [402]
Menthol DMG2KW7 Back pain ME84.Z Approved [100]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [464]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [465]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Claudin-8 (CLDN8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leuprorelin acetate DM15HAT Prostate cancer 2C82.0 Approved [466]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [380]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [49]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [467]
Tetracycline DMZA017 Acne vulgaris ED80 Approved [128]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [176]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [468]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [469]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [470]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [218]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [471]
Testosterone DM7HUNW Hot flushes GA30 Approved [472]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [473]
Capivasertib DM9SKW8 Breast cancer 2C60-2C65 Approved [474]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [475]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [476]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [477]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [478]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [479]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Daunorubicin DMQUSBT Acute monocytic leukemia Approved [480]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [180]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [148]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [481]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cyclin-A1 (CCNA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [56]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [186]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [56]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [482]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [186]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [175]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Folic Acid DMEMBJC Colorectal carcinoma Approved [126]
Atropine DMEN6X7 Organophosphate poisoning NE6Z Approved [483]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [484]
SPI-1005 DM6XFHS Reperfusion injury ND56.Z Approved [485]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [485]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [486]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [487]
Ceftazidime DM41GRA Bacteremia 1A73 Approved [485]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Chlorpheniramine DM5URA2 Allergic rhinitis CA08.0 Approved [485]
Ethacrynic acid DM60QMR Edema MG29 Approved [485]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [485]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [252]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [488]
Selenium DM25CGV N. A. N. A. Approved [23]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [97]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [489]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [490]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [491]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [492]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [493]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [104]
Methotrexate DM2TEOL Anterior urethra cancer Approved [25]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Ethanol DMDRQZU Chronic pain MG30 Approved [494]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [495]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [104]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [54]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [224]
Quinolones DM5GVHU Bacterial infection 1A00-1C4Z Approved [496]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [497]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [498]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [87]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By N-myc-interactor (NMI)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [182]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [499]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [143]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [173]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Clozapine DMFC71L Schizophrenia 6A20 Approved [188]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [500]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cyclin-G2 (CCNG2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [133]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Fluoxetine DM3PD2C Bipolar depression Approved [246]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Estrone DM5T6US Acne vulgaris ED80 Approved [133]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [119]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [87]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [87]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Occludin (OCLN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [501]
Methotrexate DM2TEOL Anterior urethra cancer Approved [502]
Quercetin DM3NC4M Obesity 5B81 Approved [503]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [85]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [504]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Thioguanine DM7NKEV Acute lymphocytic leukaemia 2B33.3 Approved [505]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [65]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Ethanol DMDRQZU Chronic pain MG30 Approved [494]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [91]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [506]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [507]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [508]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [87]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [87]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [87]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Testosterone enanthate DMB6871 N. A. N. A. Approved [113]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [89]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [33]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [201]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [509]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [510]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [25]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [511]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [511]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [107]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [87]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [87]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [187]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Krueppel-like factor 6 (KLF6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [89]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [512]
Selenium DM25CGV N. A. N. A. Approved [23]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [135]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [54]
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [74]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Leflunomide DMR8ONJ Arthritis FA20 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [165]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
QUERCITRIN DM1DH96 Discovery agent N.A. Investigative [445]
Drug(s) Affected By Protein Niban 1 (NIBAN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [513]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [95]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [514]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [187]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [99]
Ethanol DMDRQZU Chronic pain MG30 Approved [394]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [23]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [146]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [31]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Arsenic DMTL2Y1 N. A. N. A. Approved [34]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [314]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [142]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [153]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein SIX2 (SIX2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [48]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [314]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [84]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [321]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [515]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Methamphetamine DMPM4SK Anxiety Approved [516]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [517]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [141]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sal-like protein 4 (SALL4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [79]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [518]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [518]
Testosterone DM7HUNW Hot flushes GA30 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [40]
Pomalidomide DMTGBAX Plasma cell myeloma 2A83.1 Approved [518]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [68]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [320]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [265]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [146]
Panobinostat DM58WKG Chronic graft versus host disease Approved [138]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [65]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [42]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [43]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [32]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [148]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Uridine DMQTREB Depression 6A70-6A7Z Approved [519]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [50]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [129]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [116]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [520]
Adenosine DMM2NSK Paroxysmal supraventricular tachycardia BC81.Z Approved [520]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [521]
DEOXYCYTIDINE DMYE5LJ Acute myeloid leukaemia 2A60 Approved [519]
Urethane DM7NSI0 N. A. N. A. Phase 4 [151]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
DNA [cytosine-5]-methyltransferase (DNMT) TTHVCUP NOUNIPROTAC Inhibitor [3]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytidine aminohydrolase (CDA) DEKEDRC CDD_HUMAN Substrate [4]
Cytidine deaminase (cdd) DEYILK4 E0TLJ6_MYCHH Substrate [5]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (PLCB1) OT9HYT7A PLCB1_HUMAN Gene/Protein Processing [6]
15-hydroxyprostaglandin dehydrogenase (HPGD) OTYZI6JB PGDH_HUMAN Post-Translational Modifications [7]
5'-nucleotidase (NT5E) OT7J5LT6 5NTD_HUMAN Gene/Protein Processing [8]
A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1) OTTLJH8W ATS1_HUMAN Gene/Protein Processing [8]
Adenylate kinase isoenzyme 5 (AK5) OTTGXLOT KAD5_HUMAN Gene/Protein Processing [8]
Afadin- and alpha-actinin-binding protein (SSX2IP) OTEIZ7N1 ADIP_HUMAN Gene/Protein Processing [8]
Albumin (ALB) OTVMM513 ALBU_HUMAN Gene/Protein Processing [9]
Alpha-2,8-sialyltransferase 8B (ST8SIA2) OTRBBBD8 SIA8B_HUMAN Gene/Protein Processing [8]
Alpha-S1-casein (CSN1S1) OTXOW6XJ CASA1_HUMAN Gene/Protein Processing [8]
Angiogenic factor with G patch and FHA domains 1 (AGGF1) OTA7U2T8 AGGF1_HUMAN Gene/Protein Processing [10]

References

1 Azacitidine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6796).
3 The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid l... Leukemia. 2009 Jun;23(6):1019-28.
4 A pilot pharmacokinetic study of oral azacitidine. Leukemia. 2008 Sep;22(9):1680-4.
5 Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs. FEBS Open Bio. 2015 Aug 3;5:634-9.
6 Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16811-6. doi: 10.1073/pnas.0907109106. Epub 2009 Sep 10.
7 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Clin Cancer Res. 2009 Jul 15;15(14):4572-80. doi: 10.1158/1078-0432.CCR-08-2518. Epub 2009 Jul 7.
8 The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. Hum Reprod. 2010 Nov;25(11):2859-69.
9 Self-assembled 3D spheroids and hollow-fibre bioreactors improve MSC-derived hepatocyte-like cell maturation in vitro. Arch Toxicol. 2017 Apr;91(4):1815-1832.
10 The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia. 2009 Jun;23(6):1019-28.
11 Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation. Bioorg Med Chem. 2010 Jan 15;18(2):822-9.
12 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
13 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
14 DNA methyltransferase inhibitors: an updated patent review (2012-2015).Expert Opin Ther Pat. 2016 Sep;26(9):1017-30.
15 Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors. Bioorg Med Chem Lett. 2009 May 15;19(10):2742-6.
16 Genetic factors influencing cytarabine therapy. Pharmacogenomics. 2009 Oct;10(10):1657-74.
17 Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours. Br J Clin Pharmacol. 2011 Mar;71(3):437-44.
18 Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889. Int J Cancer. 2003 Sep 20;106(5):799-805.
19 Tracking decitabine incorporation into malignant myeloid cell DNA in vitro and in vivo by LC-MS/MS with enzymatic digestion. Sci Rep. 2019 Mar 14;9(1):4558.
20 Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells. Oncotarget. 2019 Jan 1;10(1):45-59. doi: 10.18632/oncotarget.26534. eCollection 2019 Jan 1.
21 Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. Mol Pharmacol. 2005 May;67(5):1808-17. doi: 10.1124/mol.104.005769. Epub 2005 Feb 9.
22 Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 1;64(9):3022-9. doi: 10.1158/0008-5472.can-03-1880.
23 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
24 Role of BAX in the apoptotic response to anticancer agents. Science. 2000 Nov 3;290(5493):989-92. doi: 10.1126/science.290.5493.989.
25 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
26 Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. Oncogene. 2005 Feb 10;24(7):1231-43. doi: 10.1038/sj.onc.1208290.
27 Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer. 2008 Aug 15;123(4):951-7. doi: 10.1002/ijc.23593.
28 Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells. Biol Pharm Bull. 2013;36(6):944-51. doi: 10.1248/bpb.b12-01004.
29 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
30 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
31 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
32 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
33 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
34 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
35 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
36 New insights into BaP-induced toxicity: role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis. Arch Toxicol. 2016 Jun;90(6):1449-58.
37 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
38 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
39 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
40 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
41 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
42 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
43 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
44 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
45 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
46 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
47 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
48 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
49 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
50 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
51 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
52 Prediction of drug-induced liver injury using keratinocytes. J Appl Toxicol. 2017 Jul;37(7):863-872. doi: 10.1002/jat.3435. Epub 2017 Jan 31.
53 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
54 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
55 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
56 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
57 Retinoic acid and hydroquinone induce inverse expression patterns on cornified envelope-associated proteins: implication in skin irritation. J Dermatol Sci. 2014 Nov;76(2):112-9. doi: 10.1016/j.jdermsci.2014.08.003. Epub 2014 Aug 26.
58 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
59 1 alpha,25-(OH)2 vitamin D3 enhances expression of the genes encoding Ca(2+)-binding proteins MRP-8 and MRP-14. Am J Physiol. 1992 Jan;262(1 Pt 1):C235-42. doi: 10.1152/ajpcell.1992.262.1.C235.
60 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
61 Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells. Biochim Biophys Acta. 2005 Sep 10;1745(2):156-65.
62 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
63 Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface. Mol Cancer. 2014 Nov 19;13:251. doi: 10.1186/1476-4598-13-251.
64 Epigenetic activation of O-linked -N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia. EBioMedicine. 2020 Apr;54:102678. doi: 10.1016/j.ebiom.2020.102678. Epub 2020 Apr 6.
65 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
66 Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies. Toxicol Appl Pharmacol. 2021 Dec 15;433:115792. doi: 10.1016/j.taap.2021.115792. Epub 2021 Nov 3.
67 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
68 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
69 Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoid. Haematologica. 2007 Jan;92(1):115-20.
70 Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells. Anticancer Res. 2015 Nov;35(11):5827-37.
71 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
72 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
73 Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009 Apr;13(2):93-103. doi: 10.1089/omi.2008.0075.
74 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
75 D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012 Oct;17(10):1079-94.
76 Arsenic trioxide induces Hsp70 expression via reactive oxygen species and JNK pathway in MDA231 cells. Life Sci. 2005 Oct 14;77(22):2783-93. doi: 10.1016/j.lfs.2005.04.024.
77 Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett. 2005 Aug 14;158(2):95-107.
78 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
79 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
80 GABA receptor subunit composition relative to insecticide potency and selectivity. Toxicol Lett. 2001 Jul 6;122(3):215-22. doi: 10.1016/s0378-4274(01)00366-6.
81 The effect of folic acid on GABA(A)-B 1 receptor subunit. Adv Exp Med Biol. 2013;775:101-9. doi: 10.1007/978-1-4614-6130-2_8.
82 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
83 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
84 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
85 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
86 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
87 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
88 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
89 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
90 S100P is selectively upregulated in tumor cell lines challenged with DNA cross-linking agents. Leuk Res. 2005 Oct;29(10):1181-90. doi: 10.1016/j.leukres.2005.03.012.
91 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
92 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
93 Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors. Leuk Res. 2007 Nov;31(11):1511-20.
94 Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ Health Perspect. 2004 May;112(7):773-81. doi: 10.1289/ehp.6753.
95 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
96 Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts. Cancer Lett. 2018 Aug 28;430:1-10. doi: 10.1016/j.canlet.2018.04.043. Epub 2018 May 5.
97 Differential gene expression of sulindac-treated human breast epithelial cells. Int J Oncol. 2005 Dec;27(6):1727-36.
98 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 2007 Mar;128(1-2):136-47.
99 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
100 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
101 Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia. Blood. 2010 Jan 14;115(2):326-30. doi: 10.1182/blood-2009-07-235051. Epub 2009 Nov 2.
102 Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. Br J Pharmacol. 2014 Oct;171(19):4464-77. doi: 10.1111/bph.12803. Epub 2014 Sep 5.
103 Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol. 2009 Nov;18(11):969-78. doi: 10.1111/j.1600-0625.2009.00884.x. Epub 2009 Apr 8.
104 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
105 Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol. 2005 Oct;79(2):108-17.
106 Study of As(2)O(3) regulating proliferation and apoptosis of Tca8113 cells by inhibiting the expression of Id-1. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1932-1937. doi: 10.1080/21691401.2019.1613419.
107 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
108 Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. Toxicol Sci. 2023 Feb 17;191(2):227-238. doi: 10.1093/toxsci/kfac131.
109 ZD1839 induces p15INK4b and causes G1 arrest by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Mol Cancer Ther. 2007 May;6(5):1579-87. doi: 10.1158/1535-7163.MCT-06-0814.
110 Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo. Cancer Biol Ther. 2004 May;3(5):470-6. doi: 10.4161/cbt.3.5.838. Epub 2004 May 9.
111 Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells. 2007 Mar;25(3):771-8. doi: 10.1634/stemcells.2006-0271. Epub 2006 Nov 30.
112 Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity. Zhonghua Xue Ye Xue Za Zhi. 2003 Jan;24(1):28-31.
113 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
114 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
115 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
116 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
117 Gene expression levels in normal human lymphoblasts with variable sensitivities to arsenite: identification of GGT1 and NFKBIE expression levels as possible biomarkers of susceptibility. Toxicol Appl Pharmacol. 2008 Jan 15;226(2):199-205. doi: 10.1016/j.taap.2007.09.004. Epub 2007 Sep 15.
118 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004.
119 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
120 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
121 Activin/nodal signaling switches the terminal fate of human embryonic stem cell-derived trophoblasts. J Biol Chem. 2015 Apr 3;290(14):8834-48.
122 Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol. 2012 Jul;41(1):369-77.
123 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
124 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
125 Evidence for a role of claudin 2 as a proximal tubular stress responsive paracellular water channel. Toxicol Appl Pharmacol. 2014 Sep 1;279(2):163-72.
126 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
127 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
128 Effects of residual levels of tetracycline on the barrier functions of human intestinal epithelial cells. Food Chem Toxicol. 2017 Nov;109(Pt 1):253-263. doi: 10.1016/j.fct.2017.09.004. Epub 2017 Sep 4.
129 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
130 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
131 Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray. Acta Pharmacol Sin. 2004 Oct;25(10):1327-33.
132 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
133 Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium. Toxicol Sci. 2016 May;151(1):88-103.
134 Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. Arch Toxicol. 2013 Jun;87(6):1103-13. doi: 10.1007/s00204-013-1018-4. Epub 2013 Feb 10.
135 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
136 Expression of the helix-loop-helix protein inhibitor of DNA binding-1 (ID-1) is activated by all-trans retinoic acid in normal human keratinocytes. Toxicol Appl Pharmacol. 2006 Aug 1;214(3):219-29. doi: 10.1016/j.taap.2005.12.015. Epub 2006 Feb 21.
137 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
138 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
139 Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals. Int J Mol Sci. 2021 Oct 12;22(20):11005. doi: 10.3390/ijms222011005.
140 Cardiac toxicity from ethanol exposure in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci. 2019 May 1;169(1):280-292.
141 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
142 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
143 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
144 Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J. 1997 Dec 15;328 ( Pt 3)(Pt 3):739-43. doi: 10.1042/bj3280739.
145 Nucleoside transport in human colonic epithelial cell lines: evidence for two Na+-independent transport systems in T84 and Caco-2 cells. Biochim Biophys Acta. 1999 Jun 9;1419(1):15-22. doi: 10.1016/s0005-2736(99)00045-0.
146 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
147 Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound. Toxicol In Vitro. 2021 Jun;73:105112. doi: 10.1016/j.tiv.2021.105112. Epub 2021 Feb 22.
148 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
149 Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol. 2005 Jul;73(3):189-98.
150 Estrogen directly activates AID transcription and function. J Exp Med. 2009 Jan 16;206(1):99-111. doi: 10.1084/jem.20080521. Epub 2009 Jan 12.
151 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
152 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
153 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
154 Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells. PLoS One. 2022 Apr 29;17(4):e0266966. doi: 10.1371/journal.pone.0266966. eCollection 2022.
155 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
156 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
157 Nicotine modulates the expression of a diverse set of genes in the neuronal SH-SY5Y cell line. J Biol Chem. 2003 May 2;278(18):15633-40.
158 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
159 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
160 Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells. Mol Cell Endocrinol. 2004 Jun 30;221(1-2):47-55. doi: 10.1016/j.mce.2004.04.010.
161 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
162 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
163 Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Cancer Med. 2017 Nov;6(11):2646-2659. doi: 10.1002/cam4.1179. Epub 2017 Sep 27.
164 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
165 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31. doi: 10.1289/ehp.10861.
166 The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects. Clin Cancer Res. 2016 May 15;22(10):2534-44. doi: 10.1158/1078-0432.CCR-15-1666. Epub 2016 Jan 5.
167 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
168 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
169 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
170 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
171 Clinical determinants of response to irinotecan-based therapy derived from cell line models. Clin Cancer Res. 2008 Oct 15;14(20):6647-55.
172 Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells. J Nutr. 2006 Jan;136(1):75-82.
173 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
174 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
175 Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. 2012 Mar;126(1):101-13.
176 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
177 Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156:106730. doi: 10.1016/j.envint.2021.106730. Epub 2021 Jun 27.
178 A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS One. 2017 May 25;12(5):e0178302. doi: 10.1371/journal.pone.0178302. eCollection 2017.
179 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
180 Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 2003;3(1):27-40.
181 Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo. Br J Haematol. 2005 Mar;128(5):636-44.
182 Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression. Cancer Res. 2005 Sep 1;65(17):7856-65. doi: 10.1158/0008-5472.CAN-05-1056.
183 p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin. PLoS One. 2011 Apr 21;6(4):e19198. doi: 10.1371/journal.pone.0019198.
184 Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis. 2006 Aug;27(8):1567-78.
185 PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med. 2006 Oct 2;203(10):2351-62.
186 Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sci. 2003 Aug 15;73(13):1705-19. doi: 10.1016/s0024-3205(03)00515-0.
187 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
188 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
189 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
190 Exposure to nerve growth factor worsens nephrotoxic effect induced by Cyclosporine A in HK-2 cells. PLoS One. 2013 Nov 7;8(11):e80113. doi: 10.1371/journal.pone.0080113. eCollection 2013.
191 Nuclear and Mitochondrial DNA Methylation Patterns Induced by Valproic Acid in Human Hepatocytes. Chem Res Toxicol. 2017 Oct 16;30(10):1847-1854. doi: 10.1021/acs.chemrestox.7b00171. Epub 2017 Sep 13.
192 Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells. Clin Cancer Res. 2007 Sep 1;13(17):5219-25. doi: 10.1158/1078-0432.CCR-07-0816.
193 Hydroxychloroquine inhibits CD154 expression in CD4(+) T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling. Arthritis Res Ther. 2017 Aug 9;19(1):183. doi: 10.1186/s13075-017-1393-y.
194 Transcriptomics and methylomics of CD4-positive T cells in arsenic-exposed women. Arch Toxicol. 2017 May;91(5):2067-2078. doi: 10.1007/s00204-016-1879-4. Epub 2016 Nov 12.
195 Controlled diesel exhaust and allergen coexposure modulates microRNA and gene expression in humans: Effects on inflammatory lung markers. J Allergy Clin Immunol. 2016 Dec;138(6):1690-1700. doi: 10.1016/j.jaci.2016.02.038. Epub 2016 Apr 24.
196 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
197 Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J. 2012 Apr;26(4):1535-48. doi: 10.1096/fj.11-198184. Epub 2011 Dec 23.
198 Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays. Physiol Genomics. 2002 Oct 29;11(2):45-52. doi: 10.1152/physiolgenomics.00064.2002.
199 Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol. 2007 May;30(5):1263-71.
200 Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation. Mutat Res. 2001 Sep 1;480-481:269-76. doi: 10.1016/s0027-5107(01)00184-1.
201 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
202 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
203 Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. J Cell Biochem. 2005 Aug 1;95(5):955-69. doi: 10.1002/jcb.20452.
204 Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes. Pharmacology. 2009;83(1):18-25. doi: 10.1159/000166183. Epub 2008 Oct 30.
205 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
206 Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity. Arch Toxicol. 2018 Jan;92(1):469-485.
207 In vitro evaluation of biomarkers of nephrotoxicity through gene expression using gentamicin. J Biochem Mol Toxicol. 2018 Sep;32(9):e22189. doi: 10.1002/jbt.22189. Epub 2018 Jul 10.
208 Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res. 2007 Apr;138(2):163-9. doi: 10.1016/j.jss.2006.05.037. Epub 2007 Jan 25.
209 Oxidative Stress-Protective and Anti-Melanogenic Effects of Loliolide and Ethanol Extract from Fresh Water Green Algae, Prasiola japonica. Int J Mol Sci. 2018 Sep 18;19(9):2825. doi: 10.3390/ijms19092825.
210 The effects of a novel synthetic retinoid, seletinoid G, on the expression of extracellular matrix proteins in aged human skin in vivo. Clin Chim Acta. 2005 Dec;362(1-2):161-9. doi: 10.1016/j.cccn.2005.06.016. Epub 2005 Aug 1.
211 Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum. 2002 Nov;46(11):3034-40. doi: 10.1002/art.10617.
212 Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1043-9. doi: 10.1161/ATVBAHA.107.139881. Epub 2007 Feb 15.
213 Quercetin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells through extracellular signal-regulated kinase. Arch Biochem Biophys. 2001 Jul 1;391(1):72-8. doi: 10.1006/abbi.2001.2402.
214 Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors. Clin Pharmacol Ther. 2006 Apr;79(4):303-15. doi: 10.1016/j.clpt.2005.12.306.
215 Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes. J Biol Chem. 2004 Jun 11;279(24):25284-93. doi: 10.1074/jbc.M402168200. Epub 2004 Apr 9.
216 Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int J Oncol. 2014 Jul;45(1):448-58.
217 The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study. Nutr J. 2005 Mar 4;4:11.
218 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
219 Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells. Toxicol Sci. 2011 Mar;120(1):109-22.
220 Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells. Environ Toxicol. 2017 Nov;32(11):2400-2413. doi: 10.1002/tox.22453. Epub 2017 Aug 10.
221 Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol Toxicol. 2021 Apr;37(2):151-175. doi: 10.1007/s10565-020-09537-1. Epub 2020 Jun 14.
222 Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics. Toxicol Lett. 2017 Nov 5;281:26-34. doi: 10.1016/j.toxlet.2017.09.001. Epub 2017 Sep 5.
223 Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004 Jul;4(7):2160-74.
224 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res. 2005 Dec 15;65(24):11676-88.
225 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
226 Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysis. Int J Cancer. 2004 Mar 20;109(2):220-9. doi: 10.1002/ijc.11692.
227 Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood. 2007 May 15;109(10):4450-60.
228 Proteomics investigation of protein expression changes in ouabain induced apoptosis in human umbilical vein endothelial cells. J Cell Biochem. 2008 Jun 1;104(3):1054-64. doi: 10.1002/jcb.21691.
229 Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells. Chem Res Toxicol. 2015 Oct 19;28(10):1903-13. doi: 10.1021/acs.chemrestox.5b00105. Epub 2015 Sep 21.
230 Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9. Oncotarget. 2016 Dec 13;7(50):83359-83377.
231 The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence. Cell Biol Toxicol. 2023 Aug;39(4):1561-1575. doi: 10.1007/s10565-022-09747-9. Epub 2022 Aug 12.
232 Role of phenytoin in wound healing: microarray analysis of early transcriptional responses in human dermal fibroblasts. Biochem Biophys Res Commun. 2004 Feb 13;314(3):661-6. doi: 10.1016/j.bbrc.2003.12.146.
233 Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis. Mol Biosyst. 2014 Jun;10(6):1332-44.
234 DNA methylation inhibits p53-mediated survivin repression. Oncogene. 2009 May 14;28(19):2046-50. doi: 10.1038/onc.2009.62. Epub 2009 Apr 13.
235 Gene expression profiling of human peri-implantation endometria between natural and stimulated cycles. Fertil Steril. 2008 Dec;90(6):2152-64.
236 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
237 Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reprod Sci. 2011 Aug;18(8):781-97.
238 Phenethyl isothiocyanate alters the gene expression and the levels of protein associated with cell cycle regulation in human glioblastoma GBM 8401 cells. Environ Toxicol. 2017 Jan;32(1):176-187.
239 Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab. 2005 Feb;90(2):936-43.
240 Increased expression of type VI collagen genes in drug-induced gingival enlargement. FEBS Lett. 1993 Nov 8;334(1):65-8. doi: 10.1016/0014-5793(93)81681-o.
241 Acinar cell-specific knockout of the PTHrP gene decreases the proinflammatory and profibrotic responses in pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1;307(5):G533-49. doi: 10.1152/ajpgi.00428.2013. Epub 2014 Jul 17.
242 All-trans retinoic acid induced hypercalcemia in a patient with acute promyelocytic leukemia: its relation to increased PTH-rP. Int J Hematol. 1994 Feb;59(2):143-4.
243 Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer. Cancer. 2007 Sep 15;110(6):1313-20. doi: 10.1002/cncr.22922.
244 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
245 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
246 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
247 Increased matrix proteins, collagen and transforming growth factor are early markers of hepatotoxicity in patients on long-term methotrexate therapy. J Toxicol Clin Toxicol. 1996;34(3):301-5. doi: 10.3109/15563659609013794.
248 Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells. Arch Toxicol. 2018 Apr;92(4):1507-1524.
249 Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway. Biomed Pharmacother. 2019 Jan;109:2043-2053. doi: 10.1016/j.biopha.2018.11.030. Epub 2018 Nov 26.
250 Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer. 2007 Dec 11;7:223.
251 Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes. Arch Toxicol. 2018 Jan;92(1):371-381.
252 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
253 Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line. Biochim Biophys Acta. 2007 Sep;1770(9):1352-9.
254 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
255 Regulation of keratinocyte growth factor and scatter factor in cyclosporin-induced gingival overgrowth. J Oral Pathol Med. 2004 Aug;33(7):391-7. doi: 10.1111/j.1600-0714.2004.00223.x.
256 Keratinocyte growth factor is upregulated by the hyperplasia-inducing drug nifedipine. Cytokine. 2000 Oct;12(10):1566-9. doi: 10.1006/cyto.2000.0756.
257 Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21737-42. doi: 10.1073/pnas.1007863107. Epub 2010 Nov 22.
258 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
259 Unique signatures of stress-induced senescent human astrocytes. Exp Neurol. 2020 Dec;334:113466. doi: 10.1016/j.expneurol.2020.113466. Epub 2020 Sep 17.
260 Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7653-8.
261 Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells. Oncol Rep. 2016 Sep;36(3):1233-42. doi: 10.3892/or.2016.4944. Epub 2016 Jul 15.
262 Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro. PLoS One. 2011;6(9):e24831. doi: 10.1371/journal.pone.0024831. Epub 2011 Sep 14.
263 Dose- and time-dependent transcriptional response of Ishikawa cells exposed to genistein. Toxicol Sci. 2016 May;151(1):71-87.
264 Combined effects of arsenic and palmitic acid on oxidative stress and lipid metabolism disorder in human hepatoma HepG2 cells. Sci Total Environ. 2021 May 15;769:144849. doi: 10.1016/j.scitotenv.2020.144849. Epub 2021 Jan 19.
265 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
266 Linking site-specific loss of histone acetylation to repression of gene expression by the mycotoxin ochratoxin A. Arch Toxicol. 2018 Feb;92(2):995-1014.
267 Regulatory role of nitric oxide on monocyte-derived dendritic cell functions. J Interferon Cytokine Res. 2003 Aug;23(8):423-31. doi: 10.1089/107999003322277838.
268 [Effects of vitamin A on the differentiation, maturation and functions of dendritic cells from cord blood]. Zhonghua Er Ke Za Zhi. 2004 May;42(5):340-3.
269 Characterization of drug-specific signaling between primary human hepatocytes and immune cells. Toxicol Sci. 2017 Jul 1;158(1):76-89.
270 Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC). Front Microbiol. 2015 Dec 22;6:1452. doi: 10.3389/fmicb.2015.01452. eCollection 2015.
271 Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest. 1998 Nov 15;102(10):1866-73. doi: 10.1172/JCI3692.
272 Systemic drugs inducing non-immediate cutaneous adverse reactions and contact sensitizers evoke similar responses in THP-1 cells. J Appl Toxicol. 2015 Apr;35(4):398-406. doi: 10.1002/jat.3033. Epub 2014 Aug 4.
273 Induction of the endoplasmic reticulum stress protein GADD153/CHOP by capsaicin in prostate PC-3 cells: a microarray study. Biochem Biophys Res Commun. 2008 Aug 8;372(4):785-91.
274 Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood. 2001 Jun 1;97(11):3466-9. doi: 10.1182/blood.v97.11.3466.
275 Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells. J Immunother. 2005 Jan-Feb;28(1):28-39. doi: 10.1097/00002371-200501000-00004.
276 Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients. J Exp Med. 2005 May 2;201(9):1503-17. doi: 10.1084/jem.20042592.
277 Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells. Regul Pept. 2008 Apr 10;147(1-3):96-109. doi: 10.1016/j.regpep.2008.01.009. Epub 2008 Feb 11.
278 Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells. Anticancer Res. 2006 Sep-Oct;26(5A):3205-15.
279 A role for neurotensin in bicalutamide resistant prostate cancer cells. Prostate. 2007 Feb 1;67(2):190-202. doi: 10.1002/pros.20518.
280 Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. Chem Res Toxicol. 2015 May 18;28(5):927-34. doi: 10.1021/tx5005248. Epub 2015 Apr 3.
281 Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes. Chem Biol Interact. 2016 Aug 5;255:31-44.
282 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
283 Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014 May;9(5):774-82. doi: 10.4161/epi.28153. Epub 2014 Feb 13.
284 Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells. Mutagenesis. 2005 Mar;20(2):139-46. doi: 10.1093/mutage/gei019. Epub 2005 Mar 22.
285 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
286 Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicol Appl Pharmacol. 2017 Nov 15;335:16-27. doi: 10.1016/j.taap.2017.09.017. Epub 2017 Sep 21.
287 BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
288 Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.
289 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891-900.
290 The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
291 Low-dose Bisphenol A exposure alters the functionality and cellular environment in a human cardiomyocyte model. Environ Pollut. 2023 Oct 15;335:122359. doi: 10.1016/j.envpol.2023.122359. Epub 2023 Aug 9.
292 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
293 Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. BMC Med Genomics. 2009 Aug 20;2:55. doi: 10.1186/1755-8794-2-55.
294 Regulation of Hepatic Cholesteryl Ester Transfer Protein Expression and Reverse Cholesterol Transport by Inhibition of DNA Topoisomerase II. J Biol Chem. 2015 Jun 5;290(23):14418-29. doi: 10.1074/jbc.M115.643015. Epub 2015 Apr 25.
295 Noncoding RNA synthesis and loss of Polycomb group repression accompanies the colinear activation of the human HOXA cluster. RNA. 2007 Feb;13(2):223-39. doi: 10.1261/rna.266707. Epub 2006 Dec 21.
296 Evaluation of developmental toxicity using undifferentiated human embryonic stem cells. J Appl Toxicol. 2015 Feb;35(2):205-18.
297 Differential regulation of proliferation, cell cycle control and gene expression in cultured human aortic and pulmonary artery endothelial cells by resveratrol. Int J Mol Med. 2010 Nov;26(5):743-9.
298 Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.
299 Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res. 2006 Dec 1;66(23):11187-93. doi: 10.1158/0008-5472.CAN-06-1274.
300 Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression. Chem Biol Interact. 2015 Dec 5;242:123-38. doi: 10.1016/j.cbi.2015.07.014. Epub 2015 Sep 25.
301 Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring). 2010 Jan;18(1):27-34. doi: 10.1038/oby.2009.208. Epub 2009 Jun 25.
302 Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. Toxicology. 2020 Dec 1;445:152603. doi: 10.1016/j.tox.2020.152603. Epub 2020 Sep 28.
303 Marine biogenics in sea spray aerosols interact with the mTOR signaling pathway. Sci Rep. 2019 Jan 24;9(1):675.
304 DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis. 2004 Jul;25(7):1293-8.
305 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
306 Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am J Respir Cell Mol Biol. 2004 May;30(5):662-70. doi: 10.1165/rcmb.2003-0267OC. Epub 2003 Nov 20.
307 Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer. Clin Cancer Res. 2012 Jun 15;18(12):3366-76.
308 Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006 Aug 1;98(5):1163-84.
309 Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. Liver Int. 2008 Aug;28(7):997-1010. doi: 10.1111/j.1478-3231.2008.01744.x. Epub 2008 Apr 15.
310 Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res Treat. 2007 Apr;102(2):157-72.
311 Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Mol Cancer. 2015 May 14;14:103. doi: 10.1186/s12943-015-0367-4.
312 Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma Cells. J Signal Transduct. 2012;2012:204236. doi: 10.1155/2012/204236. Epub 2012 Oct 9.
313 Hesperidin delays cell cycle progression into the G0/G1 phase via suspension of MAPK signaling pathway in intrahepatic cholangiocarcinoma. J Biochem Mol Toxicol. 2022 Apr;36(4):e22981. doi: 10.1002/jbt.22981. Epub 2022 Jan 4.
314 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
315 Peroxisome proliferator activated receptor gamma (PPAR-gama) ligand pioglitazone regulated gene networks in term human primary trophoblast cells. Reprod Toxicol. 2018 Oct;81:99-107.
316 Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line. Nucl Med Biol. 2006 Oct;33(7):875-82. doi: 10.1016/j.nucmedbio.2006.07.004.
317 The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J Biol Chem. 2009 Sep 4;284(36):24306-19.
318 Single-cell transcription site activation predicts chemotherapy response in human colorectal tumors. Cancer Res. 2008 Jul 1;68(13):4977-82. doi: 10.1158/0008-5472.CAN-07-6770.
319 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
320 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
321 Gene expression changes in primary human nasal epithelial cells exposed to formaldehyde in vitro. Toxicol Lett. 2010 Oct 5;198(2):289-95.
322 Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes, HepG2 cells and mouse embryonic stem cells shows conservation of regulating transcription factor networks. Mutagenesis. 2014 Jan;29(1):17-26.
323 In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells. Mol Cancer Ther. 2005 Jun;4(6):885-900.
324 Isobaric tags for relative and absolute quantitation-based proteomics analysis of the effect of ginger oil on bisphenol A-induced breast cancer cell proliferation. Oncol Lett. 2021 Feb;21(2):101. doi: 10.3892/ol.2020.12362. Epub 2020 Dec 8.
325 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
326 Molecular targets of chloropicrin in human airway epithelial cells. Toxicol In Vitro. 2017 Aug;42:247-254.
327 Identification of troglitazone responsive genes: induction of RTP801 during troglitazone-induced apoptosis in Hep 3B cells. BMB Rep. 2010 Sep;43(9):599-603. doi: 10.5483/BMBRep.2010.43.9.599.
328 Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer. Cancer Res. 2006 Mar 1;66(5):2765-77.
329 Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins. Physiol Genomics. 2004 Jan 15;16(2):204-11.
330 Persistent and non-persistent changes in gene expression result from long-term estrogen exposure of MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2011 Feb;123(3-5):140-50.
331 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
332 High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2058-63.
333 The small polyphenolic molecule kaempferol increases cellular energy expenditure and thyroid hormone activation. Diabetes. 2007 Mar;56(3):767-76. doi: 10.2337/db06-1488.
334 Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skeletal myocytes. Endocrinology. 2009 Apr;150(4):1976-83. doi: 10.1210/en.2008-0938. Epub 2008 Nov 26.
335 Effects of all-trans and 9-cis retinoic acid on differentiating human neural stem cells in vitro. Toxicology. 2023 Mar 15;487:153461. doi: 10.1016/j.tox.2023.153461. Epub 2023 Feb 16.
336 Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases. Toxicol Sci. 2019 Apr 1;168(2):430-442. doi: 10.1093/toxsci/kfy302.
337 Flubendazole and mebendazole impair migration and epithelial to mesenchymal transition in oral cell lines. Chem Biol Interact. 2018 Sep 25;293:124-132. doi: 10.1016/j.cbi.2018.07.026. Epub 2018 Jul 31.
338 Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011 Jul;26(7):1813-25.
339 Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors. Toxicol In Vitro. 2015 Sep;29(6):1231-9. doi: 10.1016/j.tiv.2014.10.012. Epub 2014 Oct 24.
340 Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells. J Immunol. 2011 Aug 15;187(4):1778-87. doi: 10.4049/jimmunol.1003919. Epub 2011 Jul 18.
341 Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells. Reprod Toxicol. 2020 Jan;91:74-91. doi: 10.1016/j.reprotox.2019.10.004. Epub 2019 Nov 8.
342 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
343 Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199). Leukemia. 2017 Sep;31(9):1872-1881. doi: 10.1038/leu.2016.382. Epub 2016 Dec 26.
344 Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.
345 Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. Mol Cancer Ther. 2012 Oct;11(10):2138-48. doi: 10.1158/1535-7163.MCT-12-0562. Epub 2012 Aug 6.
346 Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202. Endocr Relat Cancer. 2007 Jun;14(2):305-15. doi: 10.1677/ERC-06-0003.
347 Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 2013 Mar;3(3):308-23.
348 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134. doi: 10.1016/j.envres.2019.03.035. Epub 2019 Mar 18.
349 Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):166-75.
350 Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-beta-dependent mechanisms. Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):E4558-66.
351 Characterizing the genetic basis for nicotine induced cancer development: a transcriptome sequencing study. PLoS One. 2013 Jun 18;8(6):e67252.
352 The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. BMC Med Genomics. 2010 Aug 13;3:37. doi: 10.1186/1755-8794-3-37.
353 Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP-signaling pathway. Biochem Pharmacol. 2013 Feb 1;85(3):376-84. doi: 10.1016/j.bcp.2012.11.011. Epub 2012 Nov 23.
354 Inhibition of CXCL12-mediated chemotaxis of Jurkat cells by direct immunotoxicants. Arch Toxicol. 2016 Jul;90(7):1685-94. doi: 10.1007/s00204-015-1585-7. Epub 2015 Aug 28.
355 Redox/methylation mediated abnormal DNA methylation as regulators of ambient fine particulate matter-induced neurodevelopment related impairment in human neuronal cells. Sci Rep. 2016 Sep 14;6:33402. doi: 10.1038/srep33402.
356 Integrated analysis of rifampicin-induced microRNA and gene expression changes in human hepatocytes. Drug Metab Pharmacokinet. 2014;29(4):333-40.
357 Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthritis Cartilage. 2006 Mar;14(3):250-7. doi: 10.1016/j.joca.2005.10.001. Epub 2005 Nov 18.
358 Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry. 2008 Mar;65(3):345-55. doi: 10.1001/archpsyc.65.3.345.
359 A high concentration of genistein down-regulates activin A, Smad3 and other TGF-beta pathway genes in human uterine leiomyoma cells. Exp Mol Med. 2012 Apr 30;44(4):281-92.
360 A protein-coated magnetic beads as a tool for the rapid drug-protein binding study. J Pharm Biomed Anal. 2010 Jul 8;52(3):420-4. doi: 10.1016/j.jpba.2009.06.023. Epub 2009 Jun 18.
361 The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties. J Biol Chem. 1999 Oct 8;274(41):29303-10. doi: 10.1074/jbc.274.41.29303.
362 Exploring binding properties of sertraline with human serum albumin: Combination of spectroscopic and molecular modeling studies. Chem Biol Interact. 2015 Dec 5;242:235-46. doi: 10.1016/j.cbi.2015.10.006. Epub 2015 Oct 22.
363 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
364 Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates. J Chromatogr A. 2011 Apr 15;1218(15):2072-8. doi: 10.1016/j.chroma.2010.09.070. Epub 2010 Oct 16.
365 [Colchicine in chronic liver disease of alcoholic etiology. Double-blind, randomized study of its effects on blood levels of plasma proteins and clinical course in patients]. Rev Assoc Med Bras (1992). 1995 May-Jun;41(3):207-12.
366 Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues. Toxicol Sci. 2016 Dec;154(2):354-367. doi: 10.1093/toxsci/kfw169. Epub 2016 Sep 7.
367 Covalent binding of the flavonoid quercetin to human serum albumin. J Agric Food Chem. 2005 May 18;53(10):4194-7. doi: 10.1021/jf050061m.
368 Microtubule disarray in primary cultures of human hepatocytes inhibits transcriptional activity of the glucocorticoid receptor via activation of c-jun N-terminal kinase. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004 Dec;148(2):135-9.
369 Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. PLoS One. 2014 Aug 1;9(8):e104010.
370 Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures. Arch Toxicol. 2018 Jun;92(6):1939-1952.
371 Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes. Chem Biol Interact. 2009 May 15;179(2-3):288-96.
372 Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol Pharmacol. 2006 Jul;70(1):329-39.
373 Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chem Biol Interact. 2009 Apr 15;179(1):17-24.
374 C/EBPalpha inactivation in FAK-overexpressed HL-60 cells impairs cell differentiation. Cell Signal. 2006 Jul;18(7):955-63. doi: 10.1016/j.cellsig.2005.08.014. Epub 2005 Oct 14.
375 Arsenic trioxide promotes senescence and regulates the balance of adipogenic and osteogenic differentiation in human mesenchymal stem cells. Acta Biochim Biophys Sin (Shanghai). 2011 Mar;43(3):204-9. doi: 10.1093/abbs/gmq130. Epub 2011 Jan 21.
376 Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines. Antiviral Res. 2011 Aug;91(2):112-9. doi: 10.1016/j.antiviral.2011.04.018. Epub 2011 May 17.
377 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
378 Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy. Hepatology. 2009 Mar;49(3):979-88. doi: 10.1002/hep.22712.
379 The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines. BMC Med Genomics. 2008 Oct 10;1:49.
380 Prevention of murine experimental corneal trauma by epigenetic events regulating claudin 6 and claudin 9. Jpn J Ophthalmol. 2008 May-Jun;52(3):195-203. doi: 10.1007/s10384-008-0524-z. Epub 2008 Jul 27.
381 Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity. Toxicol Sci. 2002 Apr;66(2):233-43. doi: 10.1093/toxsci/66.2.233.
382 Selenite and selenomethionine promote HL-60 cell cycle progression. J Nutr. 2002 Apr;132(4):674-9. doi: 10.1093/jn/132.4.674.
383 Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. J Biochem Mol Toxicol. 2018 Jan;32(1). doi: 10.1002/jbt.22007. Epub 2017 Nov 7.
384 Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res. 2012 Aug 15;18(16):4345-55. doi: 10.1158/1078-0432.CCR-11-3227. Epub 2012 Jun 25.
385 Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res. 2002 Nov 1;62(21):6006-10.
386 Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide. J Pharm Pharmacol. 2002 Nov;54(11):1559-63. doi: 10.1211/002235702117.
387 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
388 Transient receptor potential vanilloid 1-mediated expression and secretion of endothelial cell-derived calcitonin gene-related peptide. Regul Pept. 2008 Oct 9;150(1-3):66-72. doi: 10.1016/j.regpep.2008.05.007. Epub 2008 Jun 3.
389 The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Blood. 2008 Mar 15;111(6):3097-107.
390 Positive signaling interactions between arsenic and ethanol for angiogenic gene induction in human microvascular endothelial cells. Toxicol Sci. 2008 Apr;102(2):319-27. doi: 10.1093/toxsci/kfn003. Epub 2008 Jan 8.
391 Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 2006 Jan;97(1):64-71.
392 Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J Proteome Res. 2009 Jun;8(6):3006-19.
393 Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease. Proteomics. 2008 Apr;8(8):1595-607. doi: 10.1002/pmic.200700556.
394 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
395 Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells. Int J Mol Sci. 2017 Jan 28;18(2):271. doi: 10.3390/ijms18020271.
396 In vitro antitumoral effects of the steroid ouabain on human thyroid papillary carcinoma cell lines. Environ Toxicol. 2021 Jul;36(7):1338-1348. doi: 10.1002/tox.23130. Epub 2021 Mar 24.
397 Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents. Leuk Res. 2010 Jul;34(7):917-24. doi: 10.1016/j.leukres.2009.12.002. Epub 2010 Feb 8.
398 Structural and functional studies on the human hepatic interleukin-6 receptor. Molecular cloning and overexpression in HepG2 cells. Biochem J. 1991 Aug 1;277 ( Pt 3)(Pt 3):659-64. doi: 10.1042/bj2770659.
399 Retinoic acid can induce markers of endocrine transdifferentiation in pancreatic ductal adenocarcinoma: preliminary observations from an in vitro cell line model. J Clin Pathol. 2006 Jun;59(6):603-10. doi: 10.1136/jcp.2005.032003. Epub 2006 Feb 10.
400 [Toxic effects of aluminum on human embryonic cerebral neurocytes in vitro studies]. Zhonghua Yu Fang Yi Xue Za Zhi. 2000 Mar;34(2):106-8.
401 Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature. Oncotarget. 2017 Jul 4;8(27):43678-43691. doi: 10.18632/oncotarget.18435.
402 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
403 The genomic response of Ishikawa cells to bisphenol A exposure is dose- and time-dependent. Toxicology. 2010 Apr 11;270(2-3):137-49. doi: 10.1016/j.tox.2010.02.008. Epub 2010 Feb 17.
404 Progesterone regulation of implantation-related genes: new insights into the role of oestrogen. Cell Mol Life Sci. 2007 Apr;64(7-8):1009-32.
405 Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer. Ann Surg Oncol. 2011 May;18(5):1506-11. doi: 10.1245/s10434-010-1488-z. Epub 2010 Dec 24.
406 Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. Free Radic Biol Med. 2012 Jul 1;53(1):44-50. doi: 10.1016/j.freeradbiomed.2012.04.031. Epub 2012 May 9.
407 Nitric oxide causes anoikis through attenuation of E-cadherin and activation of caspase-3 in human gastric carcinoma AZ-521 cells infected with Mycoplasma hyorhinis. J Vet Med Sci. 2010 Jul;72(7):869-74.
408 Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci. 1999 Aug;112 ( Pt 16):2657-66. doi: 10.1242/jcs.112.16.2657.
409 Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo. Chem Biol Interact. 2021 Nov 1;349:109641. doi: 10.1016/j.cbi.2021.109641. Epub 2021 Sep 14.
410 Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells. Biochem Biophys Res Commun. 2009 Mar 13;380(3):614-9. doi: 10.1016/j.bbrc.2009.01.134. Epub 2009 Jan 27.
411 Regulation of epithelial cell morphology and functions approaching to more in vivo-like by modifying polyethylene glycol on polysulfone membranes. PLoS One. 2012;7(4):e36110.
412 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells. Arch Biochem Biophys. 2009 Jul 15;487(2):139-45. doi: 10.1016/j.abb.2009.05.017. Epub 2009 Jun 6.
413 Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration. Oncotarget. 2016 Nov 22;7(47):77543-77557. doi: 10.18632/oncotarget.12721.
414 Hsa-let-7g miRNA regulates the anti-tumor effects of gastric cancer cells under oxidative stress through the expression of DDR genes. J Toxicol Sci. 2015 Jun;40(3):329-38. doi: 10.2131/jts.40.329.
415 Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity. Toxicology. 2020 Apr 15;435:152422. doi: 10.1016/j.tox.2020.152422. Epub 2020 Feb 26.
416 Synthesis and structure-activity relationships of new antiproliferative and proapoptotic retinoid-related biphenyl-4-yl-acrylic acids. Bioorg Med Chem. 2007 Jul 15;15(14):4863-75. doi: 10.1016/j.bmc.2007.04.057. Epub 2007 May 3.
417 Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2. Biochem Pharmacol. 2011 Feb 15;81(4):510-7. doi: 10.1016/j.bcp.2010.11.014. Epub 2010 Nov 27.
418 Actinomycin D inhibits the expression of the cystine/glutamate transporter xCT via attenuation of CD133 synthesis in CD133(+) HCC. Chem Biol Interact. 2019 Aug 25;309:108713. doi: 10.1016/j.cbi.2019.06.026. Epub 2019 Jun 19.
419 Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells. Ann Hematol. 2010 Nov;89(11):1115-24. doi: 10.1007/s00277-010-0988-z. Epub 2010 May 25.
420 The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib. Toxicol Sci. 2023 Dec 21;197(1):69-78. doi: 10.1093/toxsci/kfad099.
421 The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX. DNA Repair (Amst). 2004 Mar 4;3(3):235-44. doi: 10.1016/j.dnarep.2003.10.014.
422 Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006 Jan 10;24(2):274-87. doi: 10.1200/JCO.2005.02.9405. Epub 2005 Dec 19.
423 Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019 Dec;34(12):1329-1339. doi: 10.1002/tox.22834. Epub 2019 Aug 21.
424 Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage. Carcinogenesis. 2014 Mar;35(3):692-702. doi: 10.1093/carcin/bgt366. Epub 2013 Nov 5.
425 Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J Neurosurg. 2004 Oct;101(4):659-63. doi: 10.3171/jns.2004.101.4.0659.
426 Phenytoin may increase the efficacy of temozolomide by methylating DNA-repair enzyme, O6-methylguanine-DNA methyltransferase in patients with glioblastoma. Med Hypotheses. 2005;65(4):819-20. doi: 10.1016/j.mehy.2005.04.007.
427 Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide-bischloroethylnitrosourea combination therapy in patients with advanced breast cancer. Int J Cancer. 2003 Feb 20;103(5):686-92. doi: 10.1002/ijc.10849.
428 Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells. Mol Pharmacol. 2008 Aug;74(2):517-26. doi: 10.1124/mol.107.043620. Epub 2008 May 20.
429 Synergistic effects of arsenic trioxide combined with ascorbic acid in human osteosarcoma MG-63 cells: a systems biology analysis. Eur Rev Med Pharmacol Sci. 2014;18(24):3877-88.
430 Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. Oncol Rep. 2006 Jun;15(6):1453-60.
431 Chromium III histidinate exposure modulates gene expression in HaCaT human keratinocytes exposed to oxidative stress. Biol Trace Elem Res. 2010 Oct;137(1):23-39.
432 A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate. Cancer Gene Ther. 2008 Sep;15(9):576-90. doi: 10.1038/cgt.2008.28. Epub 2008 May 16.
433 Genomic profiling uncovers a molecular pattern for toxicological characterization of mutagens and promutagens in vitro. Toxicol Sci. 2011 Jul;122(1):185-97.
434 Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability. Int J Mol Sci. 2023 Mar 15;24(6):5604. doi: 10.3390/ijms24065604.
435 The Effect of GADD45a on Furazolidone-Induced S-Phase Cell-Cycle Arrest in Human Hepatoma G2 Cells. J Biochem Mol Toxicol. 2015 Oct;29(10):489-495. doi: 10.1002/jbt.21719. Epub 2015 Jun 11.
436 Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells. Oncogene. 2004 Jun 3;23(26):4614-23. doi: 10.1038/sj.onc.1207598.
437 Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. J Pharmacol Exp Ther. 2003 Jun;305(3):932-42. doi: 10.1124/jpet.103.049098. Epub 2003 Mar 20.
438 Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms. Cancer Res. 2005 Jul 15;65(14):6476-83. doi: 10.1158/0008-5472.CAN-05-0370.
439 1,25-Dihydroxyvitamin D3 suppresses gene expression of eukaryotic translation initiation factor 2 in human promyelocytic leukemia HL-60 cells. Cell Struct Funct. 2005;30(1):1-6. doi: 10.1247/csf.30.1.
440 A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway in ovarian cancer cells. Gynecol Oncol. 2011 Jan;120(1):121-7. doi: 10.1016/j.ygyno.2010.10.003. Epub 2010 Oct 29.
441 Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line. Toxicol Appl Pharmacol. 2006 Oct 1;216(1):89-97. doi: 10.1016/j.taap.2006.04.015. Epub 2006 May 19.
442 [Re-expression of p16 gene in myeloma cell line U266 by arsenic trioxide]. Ai Zheng. 2004 Jun;23(6):626-30.
443 p16 loss facilitate hydroquinone-induced malignant transformation of TK6 cells through promoting cell proliferation and accelerating the cell cycle progression. Environ Toxicol. 2021 Aug;36(8):1591-1599. doi: 10.1002/tox.23155. Epub 2021 May 1.
444 Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. Acta Oncol. 2008;47(6):1062-70.
445 Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer. Arch Med Res. 2014 Aug;45(6):445-54.
446 Cellular reactions to long-term volatile organic compound (VOC) exposures. Sci Rep. 2016 Dec 1;6:37842. doi: 10.1038/srep37842.
447 BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukoc Biol. 2012 Dec;92(6):1147-54. doi: 10.1189/jlb.0312165. Epub 2012 Jul 16.
448 The anti-cancer drug gefitinib accelerates Fas-mediated apoptosis by enhancing caspase-8 activation in cancer cells. J Toxicol Sci. 2019;44(6):435-440. doi: 10.2131/jts.44.435.
449 NF-B potentiates caspase independent hydrogen peroxide induced cell death. PLoS One. 2011 Feb 15;6(2):e16815. doi: 10.1371/journal.pone.0016815.
450 Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway. Cardiovasc Res. 2000 Feb;45(3):788-94. doi: 10.1016/s0008-6363(99)00369-7.
451 Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep. 2011 Feb;25(2):583-91. doi: 10.3892/or.2010.1097. Epub 2010 Dec 10.
452 Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells. Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1071-7. doi: 10.1097/01.meg.0000231750.68513.6c.
453 Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine. Toxicol In Vitro. 2016 Sep;35:66-76. doi: 10.1016/j.tiv.2016.05.013. Epub 2016 May 26.
454 Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis. J Clin Immunol. 2002 Jan;22(1):37-47. doi: 10.1023/a:1014256603539.
455 Rosiglitazone, an Agonist of PPARgamma, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2. PPAR Res. 2007;2007:29632. doi: 10.1155/2007/29632.
456 Involvement of C/EBP-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis. Toxicol Lett. 2019 Sep 15;312:11-21. doi: 10.1016/j.toxlet.2019.05.003. Epub 2019 May 3.
457 Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):117-27.
458 Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neuro Oncol. 2011 Mar;13(3):267-79. doi: 10.1093/neuonc/noq195. Epub 2011 Feb 3.
459 Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem. 2003 May 16;278(20):18092-100. doi: 10.1074/jbc.M300265200. Epub 2003 Mar 13.
460 TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells. J Pathol. 2011 Feb;223(3):378-89. doi: 10.1002/path.2797. Epub 2010 Oct 29.
461 Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.
462 Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol Ther. 2008 Oct;7(10):1607-18.
463 ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.
464 Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol. 2009 Mar;144(5):667-76. doi: 10.1111/j.1365-2141.2008.07504.x. Epub 2008 Nov 20.
465 Transcriptional repression of IKK by p53 in arsenite-induced GADD45 accumulation and apoptosis. Oncogene. 2019 Jan;38(5):731-746. doi: 10.1038/s41388-018-0478-7. Epub 2018 Sep 3.
466 Testosterone regulates tight junction proteins and influences prostatic autoimmune responses. Horm Cancer. 2011 Jun;2(3):145-56. doi: 10.1007/s12672-010-0063-1.
467 Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells. Toxins (Basel). 2023 Feb 9;15(2):140. doi: 10.3390/toxins15020140.
468 Cannabidiol Reduces Leukemic Cell Size - But Is It Important?. Front Pharmacol. 2017 Mar 24;8:144. doi: 10.3389/fphar.2017.00144. eCollection 2017.
469 Crizotinib-resistant mutants of EML4-ALK identified through an accelerated mutagenesis screen. Chem Biol Drug Des. 2011 Dec;78(6):999-1005. doi: 10.1111/j.1747-0285.2011.01239.x. Epub 2011 Oct 31.
470 D-glucosamine down-regulates HIF-1alpha through inhibition of protein translation in DU145 prostate cancer cells. Biochem Biophys Res Commun. 2009 Apr 24;382(1):96-101. doi: 10.1016/j.bbrc.2009.02.129. Epub 2009 Feb 28.
471 Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling. Aging (Albany NY). 2012 Dec;4(12):952-65. doi: 10.18632/aging.100521.
472 Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival. Anticancer Res. 2010 Oct;30(10):3895-901.
473 Imatinib disturbs lysosomal function and morphology and impairs the activity of mTORC1 in human hepatocyte cell lines. Food Chem Toxicol. 2022 Apr;162:112869. doi: 10.1016/j.fct.2022.112869. Epub 2022 Feb 16.
474 Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells. Oncogene. 2016 Aug 25;35(34):4518-28. doi: 10.1038/onc.2015.511. Epub 2016 Feb 8.
475 Neuroprotective effects of glucomoringin-isothiocyanate against H(2)O(2)-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells. Neurotoxicology. 2019 Dec;75:89-104. doi: 10.1016/j.neuro.2019.09.008. Epub 2019 Sep 12.
476 Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-B signaling in cervical cancer. Ann Surg Oncol. 2014 Dec;21 Suppl 4:S687-95. doi: 10.1245/s10434-014-3812-5. Epub 2014 Jul 22.
477 p38 MAPK/PP2Ac/TTP pathway on the connection of TNF- and caspases activation on hydroquinone-induced apoptosis. Carcinogenesis. 2013 Apr;34(4):818-27. doi: 10.1093/carcin/bgs409. Epub 2013 Jan 3.
478 A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia. Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3378-83.
479 Effects of metformin and pioglitazone combination on apoptosis and AMPK/mTOR signaling pathway in human anaplastic thyroid cancer cells. J Biochem Mol Toxicol. 2020 Oct;34(10):e22547. doi: 10.1002/jbt.22547. Epub 2020 Jun 26.
480 CREB/Sp1-mediated MCL1 expression and NFB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Toxicol Appl Pharmacol. 2022 Jan 15;435:115847. doi: 10.1016/j.taap.2021.115847. Epub 2021 Dec 25.
481 "Minimalist" cyclopropene-containing photo-cross-linkers suitable for live-cell imaging and affinity-based protein labeling. J Am Chem Soc. 2014 Jul 16;136(28):9990-8. doi: 10.1021/ja502780z. Epub 2014 Jul 3.
482 Targeting the Na(+)/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting. Biol Pharm Bull. 2010;33(5):743-51. doi: 10.1248/bpb.33.743.
483 Gene expression signature of parathion-transformed human breast epithelial cells. Int J Mol Med. 2007 May;19(5):741-50.
484 NRF2 transcriptionally activates the heat shock factor 1 promoter under oxidative stress and affects survival and migration potential of MCF7 cells. J Biol Chem. 2018 Dec 14;293(50):19303-19316. doi: 10.1074/jbc.RA118.003376. Epub 2018 Oct 11.
485 A Gene Expression Biomarker Predicts Heat Shock Factor 1 Activation in a Gene Expression Compendium. Chem Res Toxicol. 2021 Jul 19;34(7):1721-1737. doi: 10.1021/acs.chemrestox.0c00510. Epub 2021 Jun 25.
486 Non-steroidal anti-inflammatory drugs inhibit the expression of cytokines and induce HSP70 in human monocytes. Cytokine. 1999 May;11(5):347-58. doi: 10.1006/cyto.1998.0437.
487 Simvastatin induces heat shock factor 1 in vascular endothelial cells. Atherosclerosis. 2006 Oct;188(2):265-73. doi: 10.1016/j.atherosclerosis.2005.10.045. Epub 2005 Dec 20.
488 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
489 Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2716-23.
490 Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling. J Surg Res. 2008 Mar;145(1):66-73. doi: 10.1016/j.jss.2007.04.039. Epub 2007 Jul 20.
491 Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. Immunology. 2007 May;121(1):71-81. doi: 10.1111/j.1365-2567.2006.02539.x.
492 Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells. Eur J Pharmacol. 2010 Jun 10;635(1-3):219-26. doi: 10.1016/j.ejphar.2010.02.044. Epub 2010 Mar 20.
493 Cannabidiol induces osteoblast differentiation via angiopoietin1 and p38 MAPK. Environ Toxicol. 2020 Dec;35(12):1318-1325. doi: 10.1002/tox.22996. Epub 2020 Jul 13.
494 Ethanol impairs intestinal barrier function in humans through mitogen activated protein kinase signaling: a combined in vivo and in vitro approach. PLoS One. 2014 Sep 16;9(9):e107421. doi: 10.1371/journal.pone.0107421. eCollection 2014.
495 Hydrocortisone enhances the barrier properties of HBMEC/ci, a brain microvascular endothelial cell line, through mesenchymal-to-endothelial transition-like effects. Fluids Barriers CNS. 2015 Mar 5;12:7. doi: 10.1186/s12987-015-0003-0. eCollection 2015.
496 Impairment of hypoxia-induced HIF-1 signaling in keratinocytes and fibroblasts by sulfur mustard is counteracted by a selective PHD-2 inhibitor. Arch Toxicol. 2016 May;90(5):1141-50. doi: 10.1007/s00204-015-1549-y. Epub 2015 Jun 17.
497 Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene. 2005 Feb 3;24(6):980-91. doi: 10.1038/sj.onc.1208095.
498 Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3767-77.
499 Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells. Toxicol Appl Pharmacol. 2009 Nov 1;240(3):355-66.
500 CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy. Arch Toxicol. 2023 Feb;97(2):441-456. doi: 10.1007/s00204-022-03404-0. Epub 2022 Nov 6.
501 Protective effect of quercetin on hydrogen peroxide-induced tight junction disruption. Int J Toxicol. 2010 Jul;29(4):418-24. doi: 10.1177/1091581810366487. Epub 2010 May 5.
502 Development of an alternative zebrafish model for drug-induced intestinal toxicity. J Appl Toxicol. 2018 Feb;38(2):259-273. doi: 10.1002/jat.3520. Epub 2017 Oct 13.
503 Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. J Nutr. 2009 May;139(5):965-74. doi: 10.3945/jn.108.100867. Epub 2009 Mar 18.
504 Arsenite-induced downregulation of occludin in mouse lungs and BEAS-2B cells via the ROS/ERK/ELK1/MLCK and ROS/p38 MAPK signaling pathways. Toxicol Lett. 2020 Oct 10;332:146-154. doi: 10.1016/j.toxlet.2020.07.010. Epub 2020 Jul 16.
505 The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia. Clin Pharmacol Ther. 2006 Oct;80(4):375-83. doi: 10.1016/j.clpt.2006.07.002.
506 The PPAR gamma agonist troglitazone induces musclin mRNA expression in human myotubes. Horm Metab Res. 2006 Sep;38(9):614-6. doi: 10.1055/s-2006-951310.
507 Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression. Biochim Biophys Acta. 2006 Mar-Apr;1759(3-4):141-51. doi: 10.1016/j.bbaexp.2006.04.005. Epub 2006 Apr 27.
508 Role of sirtuin 1 in the regulation of hepatic gene expression by thyroid hormone. J Biol Chem. 2013 Jan 11;288(2):807-18. doi: 10.1074/jbc.M112.437970. Epub 2012 Dec 3.
509 The retinoid anticancer signal: mechanisms of target gene regulation. Br J Cancer. 2005 Aug 8;93(3):310-8. doi: 10.1038/sj.bjc.6602700.
510 Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. Blood. 2005 Feb 1;105(3):1214-21. doi: 10.1182/blood-2004-03-1182. Epub 2004 Sep 28.
511 Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells. Mutat Res. 2011 Sep 18;724(1-2):76-85. doi: 10.1016/j.mrgentox.2011.06.003. Epub 2011 Jun 17.
512 Oxidative stress modulates KLF6Full and its splice variants. Alcohol Clin Exp Res. 2012 Nov;36(11):1851-62. doi: 10.1111/j.1530-0277.2012.01798.x. Epub 2012 Apr 6.
513 Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells. Nat Commun. 2018 Aug 9;9(1):3069. doi: 10.1038/s41467-018-05402-2.
514 Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion. Toxicol In Vitro. 2009 Apr;23(3):486-99.
515 Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
516 Inhibition of PLC1 signaling pathway regulates methamphetamine self-administration and neurotoxicity in rats. Food Chem Toxicol. 2021 Mar;149:111970. doi: 10.1016/j.fct.2021.111970. Epub 2021 Jan 7.
517 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
518 Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome. Elife. 2018 Aug 1;7:e38430. doi: 10.7554/eLife.38430.
519 Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1. Nucleosides Nucleotides Nucleic Acids. 2000 Jan-Feb;19(1-2):415-34. doi: 10.1080/15257770008033018.
520 Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). Am J Physiol. 1997 Feb;272(2 Pt 1):C707-14. doi: 10.1152/ajpcell.1997.272.2.C707.
521 Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation. Mol Cancer Ther. 2009 Jan;8(1):225-31. doi: 10.1158/1535-7163.MCT-08-0743.